BRD2 and neoplasm: The tumor volume was significantly reduced in the CBD-Fab-treated mice on day 30; the tumor volumes of the mice treated with PBS and NAT-Fab were estimated to be 2,489.483 ± 40.315 mm3 and 1,940.88 ± 38.48 mm3, respectively, whereas the volumes of the CBD-Fab and cetuximab groups were 745.41 ± 39.16 mm3 and 880.484 ± 120.632 mm3, respectively (Fig. 7a).